Last reviewed · How we verify
Diclofenac, Paracetamol, Ibuprofen
At a glance
| Generic name | Diclofenac, Paracetamol, Ibuprofen |
|---|---|
| Sponsor | University of Oulu |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Helping Osteoarthritis Patients to Walk With NSAID (PHASE4)
- Efficacy of Low-Intensity Shockwave Therapy in Treating Radiation Cystitis (EARLY_PHASE1)
- Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)
- Analgesic Effects of Intranasal Diclofenac Sodium, Ibuprofen, and Paracetamol in Pediatric Tonsillectomy Cases (PHASE3)
- Effectiveness of Conventional Therapy Plus Pulsed-Radiofrequency for Herniated Nucleus Pulposus (NA)
- A COMPARISON OF TRANSDERMAL DICLOFENAC AND ORAL COMBINATION OF PARACETAMOL AND IBUPROFEN IN POSTOPERATIVE PAIN MANAGEMENT FOLLOWING SURGICAL EXTRACTION OF MANDIBULAR THIRD MOLAR- A RANDOMISD CONTROLLED TRIALS. (PHASE4)
- Delirium in Elderly Patients With Trauma of the Hip (PHASE4)
- Post-Operative Pain Control Following Shoulder Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diclofenac, Paracetamol, Ibuprofen CI brief — competitive landscape report
- Diclofenac, Paracetamol, Ibuprofen updates RSS · CI watch RSS
- University of Oulu portfolio CI